Nov 28, 2023 / 01:30PM GMT
Operator
Good morning. My name is Rob, and I will be your conference operator today. I would like to welcome everyone to the call.
(Operator Instructions)
I'd like to introduce Beth DelGiacco, Vice President, Global Head of Corporate Communications and Investor Relations. You may now begin your conference.
Beth DelGiacco - argenx SE - VP and Global Head of Corporate Communications & IR
Thank you, Rob, and to everyone for joining us today. A press release was issued this morning with the top line results from the ADVANCE subcu study of VYVGART Hytrulo in primary immune thrombocytopenia. We have a short slide deck to accompany our remarks this morning. We will not guide you through the slides in the script, but they are available on the Investors section of our website for your reference.
Before we begin, I'd like to remind you that forward-looking statements may be presented during this call. These may include statements about our future expectations, clinical development, regulatory time lines, the potential success of our product
argenx SE Investor Call Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers